SV

Sreedharan Vayakkara Padannakot

Director Whole-Time Director DIN 00371075
DIN 00371075 First appointment Jun 1997 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 1997
Shareholding value •••• Premium profile

About Sreedharan Vayakkara Padannakot

Data last updated:

Sreedharan Vayakkara Padannakot was a Whole-Time Director at Mckinley Biogenics Private Limited (2009–2017) and Director at Spenchem Pharmaceuticals Private Limited (1997–2008). The companies operate in Trading and Pharma.

DIN 00371075
Primary Designation Whole-Time Director
Industry Trading
First Appointment 07 Jun 1997

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mckinley Biogenics Private Limited U24230TN2009PTC072017
Whole-Time Director19 Jun 20092009₹1.82 Cr (FY 2017)Strike Off
Director07 Jun 19971997₹4.21 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mckinley Biogenics Private Limited
Spenchem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sreedharan Vayakkara Padannakot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreedharan Vayakkara Padannakot

Sreedharan Vayakkara Padannakot was first appointed on 07 Jun 1997 as Director at Spenchem Pharmaceuticals Private Limited. The most recent appointment on record is 19 Jun 2009 at Mckinley Biogenics Private Limited.

Sreedharan Vayakkara Padannakot held 2 earlier board appointments: Mckinley Biogenics Private Limited (Whole-Time Director, 19 Jun 2009 to 10 Nov 2017); Spenchem Pharmaceuticals Private Limited (Director, 07 Jun 1997 to 01 Jul 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available